PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells

PURPOSE OF REVIEW: Proprotein convertase subtilisin/kexin type-9 (PCSK9) binds to LDL receptor (LDLR) and targets it for lysosomal degradation in cells. Decreased hepatic clearance of plasma LDL-cholesterol is the primary gauge of PCSK9 activity in humans; however, PCSK9's evolutionary role may...

Descripción completa

Detalles Bibliográficos
Autor principal: Lagace, Thomas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
ATHEROSCLEROSIS: CELL BIOLOGY AND LIPOPROTEINS: Edited by Andrew Newby and Yury Miller
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166010/
https://www.ncbi.nlm.nih.gov/pubmed/25110901
http://dx.doi.org/10.1097/MOL.0000000000000114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166010/
https://www.ncbi.nlm.nih.gov/pubmed/25110901
http://dx.doi.org/10.1097/MOL.0000000000000114

Ejemplares similares